Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Thornburg Income Builder Opportunities Trust
$580,000,000
IPOCo-Manager
July 2021
Adial Pharmaceuticals
$5,000,000
PIPEFinancial Advisor
July 2021
Western Asset Diversified Income Fund
$1,000,000,000
IPOCo-Manager
June 2021
Golden Path Acquisition Corporation
$57,500,000
IPOCo-Manager
June 2021
Global Consumer Acquisition Corp.
$170,000,000
IPOCo-Manager
June 2021
Creatd
$2,600,000
Follow-OnCo-Manager
June 2021
Scientific Industries
$9,500,000
PIPESole Placement Agent
June 2021
Nabors Industries
$623,700,000
Warrant Dividend to All Common Shareholders
June 2021
Neuberger Berman Next Generation Connectivity Fund
$1,500,000,000
IPOCo-Manager
May 2021
Nuveen Core Plus Impact Fund
$575,000,000
IPOCo-Manager
April 2021
Protagenic Therapeutics
$13,200,000
Follow-OnCo-Manager
April 2021
Nuveen Variable Rate Preferred & Income Fund
$575,000,000
IPOCo-Manager
April 2021
Ace Global Business Acquisition Ltd.
$46,000,000
IPOJoint Bookrunner
April 2021
Imunon
$15,000,000
Registered DirectCo-Placement Agent
March 2021
Imunon
Completed EngagementCapital Markets Advisor
March 2021
BlackRock Innovation & Growth Trust
$4,400,000,000
IPOCo-Manager
March 2021
Cyclacel Pharmaceuticals
$14,500,000
Follow-OnCo-Manager
March 2021
Aseptiscope
$6,100,000
Series A Convertible Preferred StockExclusive Placement Agent
March 2021
RiverNorth Flexible Municipal Income Fund II
$440,000,000
IPOCo-Manager
February 2021
TH Plasma
$10,000,000
Series B Convertible Preferred StockExclusive Placement Agent
February 2021
Venus Acquisition Corporation
$46,000,000
IPOJoint Bookrunner
February 2021
Genocea Biosciences
Completed EngagementCapital Markets Advisor
February 2021
CNS Pharmaceuticals
$20,000,000
ATMJoint Sales Agent
February 2021
Veru
$115,000,000
Follow-OnCo-Manager
February 2021